User profiles for M. Thomassen
 | Mary Jane ThomassenProfessor, East Carolina University Verified email at ecu.edu Cited by 9464 |
The OncoArray Consortium: a network for understanding the genetic architecture of common cancers
Background: Common cancers develop through a multistep process often including inherited
susceptibility. Collaboration among multiple institutions, and funding from multiple sources, …
susceptibility. Collaboration among multiple institutions, and funding from multiple sources, …
Hereditary breast cancer: clinical, pathological and molecular characteristics
MJ Larsen, M Thomassen… - Breast cancer: basic …, 2014 - journals.sagepub.com
Pathogenic mutations in BRCA1 or BRCA2 are only detected in 25% of families with a
strong history of breast cancer, though hereditary factors are expected to be involved in the …
strong history of breast cancer, though hereditary factors are expected to be involved in the …
Conceptualizing context in entrepreneurship education: a literature review
ML Thomassen, K Williams Middleton… - International Journal of …, 2020 - emerald.com
Purpose Context impacts the design and practice of entrepreneurship education, but there is
limited focus on context in entrepreneurship education literature. The purpose of this paper …
limited focus on context in entrepreneurship education literature. The purpose of this paper …
Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 …
…, M Thomassen, AM Gerdes, T Kruse, M Caligo… - … Biomarkers & Prevention, 2012 - AACR
Background: Previously, small studies have found that BRCA1 and BRCA2 breast tumors
differ in their pathology. Analysis of larger datasets of mutation carriers should allow further …
differ in their pathology. Analysis of larger datasets of mutation carriers should allow further …
Life cycle assessment of conventional and organic milk production in the Netherlands
MA Thomassen, KJ van Calker, MCJ Smits… - Agricultural systems, 2008 - Elsevier
… On-farm land use of the organic system (1.1 m 2 /kg FPCM) was higher (p < 0.01) compared
with the conventional system (0.64 m 2 /kg FPCM), which was due mainly to lower yields (no …
with the conventional system (0.64 m 2 /kg FPCM), which was due mainly to lower yields (no …
A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor–negative breast cancer in the general …
…, J Rantala, H Ehrencrona, AM Gerdes, M Thomassen… - Nature …, 2010 - nature.com
Germline BRCA1 mutations predispose to breast cancer. To identify genetic modifiers of this
risk, we performed a genome-wide association study in 1,193 individuals with BRCA1 …
risk, we performed a genome-wide association study in 1,193 individuals with BRCA1 …
[HTML][HTML] Attributional and consequential LCA of milk production
MA Thomassen, R Dalgaard, R Heijungs… - The International Journal …, 2008 - Springer
Background, aim and scope Different ways of performing a life cycle assessment (LCA) are
used to assess the environmental burden of milk production. A strong connection exists …
used to assess the environmental burden of milk production. A strong connection exists …
Cancer Risks Associated With BRCA1 and BRCA2 Pathogenic Variants
…, MB Terry, M Thomassen, M Tischkowitz… - Journal of Clinical …, 2022 - ascopubs.org
PURPOSE To provide precise age-specific risk estimates of cancers other than female breast
and ovarian cancers associated with pathogenic variants (PVs) in BRCA1 and BRCA2 for …
and ovarian cancers associated with pathogenic variants (PVs) in BRCA1 and BRCA2 for …
Comparison of anticoagulant and procoagulant activities of stimulated platelets and platelet-derived microparticles
G Tans, J Rosing, MC Thomassen, MJ Heeb, RF Zwaal… - 1991 - ashpublications.org
Activation of human platelets considerably enhanced their ability to accelerate factor Va
inactivation by activated protein C (APC). The anticoagulant activity of platelet suspensions was …
inactivation by activated protein C (APC). The anticoagulant activity of platelet suspensions was …
[HTML][HTML] Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk
…, CF Singer, E Friedman, M Thomassen… - PLoS …, 2013 - journals.plos.org
BRCA1-associated breast and ovarian cancer risks can be modified by common genetic
variants. To identify further cancer risk-modifying loci, we performed a multi-stage GWAS of …
variants. To identify further cancer risk-modifying loci, we performed a multi-stage GWAS of …